ArticleJournal for immunotherapy of cancer2021

Oncolytic herpesvirus expressing PD-L1 BiTE for cancer therapy: exploiting tumor immune suppression as an opportunity for targeted immunotherapy.

Hena Khalique et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.